Don't miss out on Part II of our four-part blog post series on the importance of FAIR data principles to pharmaceutical organizations. In this post, we discuss data accessibility, enterprise-grade security and governance. #pharma https://t.co/r1ny2LZ49k
Don't miss out on Part II of our four-part blog post series on the importance of FAIR data principles to pharmaceutical organizations. In this post, we discuss data accessibility, enterprise-grade security and governance. #pharma https://t.co/AsPlUm9Uoe
Learn how the @MarkLogic Pharma Research Hub is eliminating key data challenges hindering pharma R&D, read @FoxBigdata's blog post https://t.co/WatG9b7yP5
“When our systems are inflexible, we are vulnerable” @StanMcChrystal explaining why terrorists initially had upper hand - and how JSOC needed to adapt #MLW19